All Posts: immunotherapy

18 Articles

News Release

New Understanding of How to Harness the Immune System to Fight Cancer

Researchers at Georgetown Lombardi have identified a new way to reprogram T cells so that they have a superior memory, thereby making them more effective in killing cancer cells.…

January 14, 2026

News Release

Clinical Study Deepens Understanding of Mesothelioma and Opens the Door to Potential Treatment Options

People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of…

September 8, 2025

GUMC Stories

Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?

For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells…

February 2, 2024

GUMC Stories

Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope

Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that…

January 18, 2024

News Release

New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients

A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a…

April 28, 2023

GUMC Stories

Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People With Melanoma

Results from a pair of clinical trials published in recent months have changed the treatment landscape for people with advanced melanoma, offering a clearer path for improved…

March 1, 2023

News Release

The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology

October 6, 2022

News Release

Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy

September 27, 2022

GUMC Stories

Eliminating the Need for Anti-Rejection Drugs for Transplant Recipients

(January 9, 2022) — Courtney Howard, 43, needed a kidney transplant to save her life and be cured of hereditary polycystic kidney disease. While she knew the kidney transplant…

January 9, 2022

News Release

Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma

November 15, 2021